Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis

NCT06800157 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Longwood Biopharmaceuticals Co., Ltd.